Is One Weight Loss Medicine Enough? What the 2026 JAMA Summit on Obesity Says In November 2026, JAMA published a report from the JAMA Summit on Obesity. It says about 1 in 9 US adults now take a GLP-1 medicine, many people stop within the first year, and no single intervention will be enough. The experts call for ongoing, team-based care and for judging progress on more than weight. Education only; a licensed provider decides every treatment. Is a weight loss medicine enough on its own? Not on its own, according to a November 2026 JAMA Summit report on obesity, which says no single intervention will be enough. HOO Longevity in the United States connects you with a licensed provider who builds a long-run plan around food, movement and regular check-ins. Sources: JAMA, 2026: https://jamanetwork.com/journals/jama/fullarticle/2856764 Learn this with HOO Longevity Academy by Join HOO Health: research-backed lessons and a new reel, carousel and story every day, in your own brand. Free Academy Live class every Tuesday evening. joinhoohealth.com/academy Education only, not medical advice. Rx programs require an online visit with a licensed provider. Results vary. #weightcare #metabolichealth #healthyhabits #Shorts #HOOLongevityAcademy #JoinHOOHealth